Details

Autor(en) / Beteiligte

• Brunoni, André Russowsky
• Suen, Paulo Jeng Chian
• Bacchi, Pedro Starzynski
• Razza, Lais Boralli
• Klein, Izio
• dos Santos, Leonardo Afonso
• de Souza Santos, Itamar
• da Costa Lane Valiengo, Leandro
• Gallucci-Neto, José
• Moreno, Marina Lopes
• Pinto, Bianca Silva
• de Cássia Silva Félix, Larissa
• de Sousa, Juliana Pereira
• Viana, Maria Carmen
• Forte, Pamela Marques
• de Altisent Oliveira Cardoso, Marcia Cristina
• Bittencourt, Marcio Sommer
• Pelosof, Rebeca
• de Siqueira, Luciana Lima
• Fatori, Daniel
• Bellini, Helena
• Bueno, Priscila Vilela Silveira
• Passos, Ives Cavalcante
• Nunes, Maria Angelica
• Salum, Giovanni Abrahão
• Bauermeister, Sarah
• Smoller, Jordan W.
• Lotufo, Paulo Andrade
• Benseñor, Isabela Martins

Titel

Prevalence and risk factors of psychiatric symptoms and diagnoses before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 mental health cohort

Ist Teil von

• Psychological medicine, 2023-01, Vol.53 (2), p.446-457

Ort / Verlag

Cambridge, UK: Cambridge University Press

Erscheinungsjahr

2023

Quelle

Applied Social Sciences Index & Abstracts (ASSIA)

Beschreibungen/Notizen

• There is mixed evidence on increasing rates of psychiatric disorders and symptoms during the coronavirus disease 2019 (COVID-19) pandemic in 2020. We evaluated pandemic-related psychopathology and psychiatry diagnoses and their determinants in the Brazilian Longitudinal Study of Health (ELSA-Brasil) São Paulo Research Center. Between pre-pandemic ELSA-Brasil assessments in 2008-2010 (wave-1), 2012-2014 (wave-2), 2016-2018 (wave-3) and three pandemic assessments in 2020 (COVID-19 waves in May-July, July-September, and October-December), rates of common psychiatric symptoms, and depressive, anxiety, and common mental disorders (CMDs) were compared using the Clinical Interview Scheduled-Revised (CIS-R) and the Depression Anxiety Stress Scale-21 (DASS-21). Multivariable generalized linear models, adjusted by age, gender, educational level, and ethnicity identified variables associated with an elevated risk for mental disorders. In 2117 participants (mean age 62.3 years, 58.2% females), rates of CMDs and depressive disorders did not significantly change over time, oscillating from 23.5% to 21.1%, and 3.3% to 2.8%, respectively; whereas rate of anxiety disorders significantly decreased (2008-2010: 13.8%; 2016-2018: 9.8%; 2020: 8%). There was a decrease along three wave-COVID assessments for depression [ = -0.37, 99.5% confidence interval (CI) -0.50 to -0.23], anxiety ( = -0.37, 99.5% CI -0.48 to -0.26), and stress ( = -0.48, 99.5% CI -0.64 to -0.33) symptoms (all s < 0.001). Younger age, female sex, lower educational level, non-white ethnicity, and previous psychiatric disorders were associated with increased odds for psychiatric disorders, whereas self-evaluated good health and good quality of relationships with decreased risk. No consistent evidence of pandemic-related worsening psychopathology in our cohort was found. Indeed, psychiatric symptoms slightly decreased along 2020. Risk factors representing socioeconomic disadvantages were associated with increased odds of psychiatric disorders.